Skip to main navigation
Skip to search
Skip to main content
Sefako Makgatho Health Sciences University Home
Search content at Sefako Makgatho Health Sciences University
Home
Profiles
Departments
Research output
Activities
Aspirin: Friend or Foe? Friend or Foe?
Elmien Bronkhorst
*
, Hanneke De Klerk
*
Corresponding author for this work
Clinical Pharmacy
Research output
:
Contribution to journal
›
Literature review
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Aspirin: Friend or Foe? Friend or Foe?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Aspirin
100%
Low-dose Aspirin
100%
Cardiovascular Disease
50%
Cyclooxygenase-1 (COX-1)
50%
Risk Factors
25%
During Pregnancy
25%
Secondary Prevention
25%
Antihypertensive Drugs
25%
Myocardial Infarction
25%
Gastrointestinal Bleeding
25%
Potential Gains
25%
Blood Pressure
25%
Old Drugs
25%
Cerebrovascular Disease
25%
Thrombosis
25%
Patient Treatment
25%
Isozymes
25%
Colon Cancer
25%
Platelets
25%
Treatment Needs
25%
Diuretics
25%
Bleeding
25%
Prostacyclin
25%
Angiotensin-converting Enzyme Inhibitor (ACEi)
25%
Atherothrombotic Event
25%
Stroke Event
25%
Potential Harm
25%
Thromboxane A2 (TXA2)
25%
Regular Basis
25%
Acetylation
25%
Thromboxane
25%
Renal Impairment
25%
Antiplatelet Therapy
25%
Antithrombotic Effect
25%
Preeclampsia
25%
Intracranial Hemorrhage
25%
Pharmacology, Toxicology and Pharmaceutical Science
Acetylsalicylic Acid
100%
Cardiovascular Disease
25%
Anticoagulant Agent
12%
Antihypertensive Agent
12%
Heart Infarction
12%
Gastrointestinal Hemorrhage
12%
Prostaglandin Synthase
12%
Brain Hemorrhage
12%
Preeclampsia
12%
Dipeptidyl Carboxypeptidase Inhibitor
12%
Thromboxane A2
12%
Cerebrovascular Disease
12%
Diuretic Agent
12%
Thrombosis
12%
Thromboxane
12%
Antiplatelet
12%
Prostacyclin
12%
Cerebrovascular Accident
12%
Isoenzyme
12%
Colon Carcinoma
12%